Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback